GLP-1 Receptor Agonists in Aesthetic Surgery: A Narrative Review on Perioperative Safety, Sarcopenic Morphologies, and Adapted Body Contouring Strategies
Aesthetic Plastic Surgery · 2026-08 · 50 (15) · 6150-6160
DOI: 10.1007/s00266-026-05980-3 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Aesthetic Plastic Surgery, online erschienen am 15.06.2026. Verfasst von Mario Venza und 1 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Plastic Surgery, Department of BIOMORF, University of Messina, Via Consolare Valeria 1, 98125, Messina, Italy. mario.venza@unime.it. Hauptthemen laut MEDLINE: Body Contouring, Glucagon-Like Peptide-1 Receptor Agonists, Obesity. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unit of Plastic Surgery, Department of BIOMORF, University of Messina, Via Consolare Valeria 1, 98125, Messina, Italy. mario.venza@unime.it.
- Unit of Ophthalmology, Department of BIOMORF, University of Messina, Messina, Italy.
Zitieren
APA
Venza, M., & Venza, I. (2026). GLP-1 Receptor Agonists in Aesthetic Surgery: A Narrative Review on Perioperative Safety, Sarcopenic Morphologies, and Adapted Body Contouring Strategies. Aesthetic Plastic Surgery, 50(15), 6150-6160. https://doi.org/10.1007/s00266-026-05980-3
Vancouver
Venza M, Venza I. GLP-1 Receptor Agonists in Aesthetic Surgery: A Narrative Review on Perioperative Safety, Sarcopenic Morphologies, and Adapted Body Contouring Strategies. Aesthetic Plastic Surgery. 2026;50(15):6150-6160. doi:10.1007/s00266-026-05980-3
BibTeX
@article{Venza2026,
author = {Venza, Mario and Venza, Isabella},
title = {GLP-1 Receptor Agonists in Aesthetic Surgery: A Narrative Review on Perioperative Safety, Sarcopenic Morphologies, and Adapted Body Contouring Strategies},
journal = {Aesthetic Plastic Surgery},
year = {2026},
volume = {50},
number = {15},
pages = {6150--6160},
doi = {10.1007/s00266-026-05980-3}
}
EUVIMED